These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17641815)

  • 21. Diabetes and parkinsonian signs in older persons.
    Arvanitakis Z; Wilson RS; Bienias JL; Bennett DA
    Alzheimer Dis Assoc Disord; 2007; 21(2):144-9. PubMed ID: 17545740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological abnormalities in cognitively impaired but not demented elderly.
    Kumamoto T; Sannomiya K; Ueyama H; Aoki K; Nakashima T; Nakamura R; Tsuda T
    Acta Neurol Scand; 2000 Nov; 102(5):292-8. PubMed ID: 11083505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of parkinsonism with visual inspection of posture and gait in the early stage.
    Lee SM; Kim M; Lee HM; Kwon KY; Kim HT; Koh SB
    Gait Posture; 2014 Apr; 39(4):1138-41. PubMed ID: 24485920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results.
    Feldman H; Levy AR; Hsiung GY; Peters KR; Donald A; Black SE; Bouchard RW; Gauthier SG; Guzman DA; Hogan DB; Kertesz A; Rockwood K;
    Neuroepidemiology; 2003; 22(5):265-74. PubMed ID: 12902621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease.
    Olazarán J; Hernández-Tamames JA; Molina E; García-Polo P; Dobato JL; Álvarez-Linera J; Martínez-Martín P;
    J Alzheimers Dis; 2013; 33(2):495-505. PubMed ID: 23011219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative gait dysfunction and risk of cognitive decline and dementia.
    Verghese J; Wang C; Lipton RB; Holtzer R; Xue X
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):929-35. PubMed ID: 17237140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.
    Peters KR; Rockwood K; Black SE; Bouchard R; Gauthier S; Hogan D; Kertesz A; Loy-English I; Beattie BL; Sadovnick AD; Feldman HH
    Neurology; 2006 Feb; 66(4):523-8. PubMed ID: 16505306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reciprocal risks of stroke and cognitive impairment in an elderly population.
    Jin YP; Di Legge S; Ostbye T; Feightner JW; Hachinski V
    Alzheimers Dement; 2006 Jul; 2(3):171-8. PubMed ID: 19595880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Odor identification and progression of parkinsonian signs in older persons.
    Wilson RS; Arnold SE; Buchman AS; Tang Y; Bennett DA
    Exp Aging Res; 2008; 34(3):173-87. PubMed ID: 18568978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy.
    De Ronchi D; Berardi D; Menchetti M; Ferrari G; Serretti A; Dalmonte E; Fratiglioni L
    Dement Geriatr Cogn Disord; 2005; 19(2-3):97-105. PubMed ID: 15591799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Relationships Between Cognitive Decline and Gait Slowing: The Tasmanian Study of Cognition and Gait.
    Callisaya ML; Blizzard CL; Wood AG; Thrift AG; Wardill T; Srikanth VK
    J Gerontol A Biol Sci Med Sci; 2015 Oct; 70(10):1226-32. PubMed ID: 26009641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild cognitive impairment and everyday functioning in older adults.
    Tuokko H; Morris C; Ebert P
    Neurocase; 2005 Feb; 11(1):40-7. PubMed ID: 15804923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and severity of cognitive impairment with and without dementia in an elderly population.
    Graham JE; Rockwood K; Beattie BL; Eastwood R; Gauthier S; Tuokko H; McDowell I
    Lancet; 1997 Jun; 349(9068):1793-6. PubMed ID: 9269213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive decline in high-functioning older adults: reserve or ascertainment bias?
    Tuokko H; Garrett DD; McDowell I; Silverberg N; Kristjansson B
    Aging Ment Health; 2003 Jul; 7(4):259-70. PubMed ID: 12888437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of community-residing older adults with frontal and parkinsonian gaits.
    Ambrose A; Levalley A; Verghese J
    J Neurol Sci; 2006 Oct; 248(1-2):215-8. PubMed ID: 16765380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population.
    Prencipe M; Santini M; Casini AR; Pezzella FR; Scaldaferri N; Culasso F
    J Neurol; 2003 Aug; 250(8):907-12. PubMed ID: 12928907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognition and mortality in older people: the Sydney Memory and Ageing Study.
    Connors MH; Sachdev PS; Kochan NA; Xu J; Draper B; Brodaty H
    Age Ageing; 2015 Nov; 44(6):1049-54. PubMed ID: 26504121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological signs, aging, and the neurodegenerative syndromes.
    Waite LM; Broe GA; Creasey H; Grayson D; Edelbrock D; O'Toole B
    Arch Neurol; 1996 Jun; 53(6):498-502. PubMed ID: 8660150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism.
    Jain S; Park SY; Comer D
    Neuroepidemiology; 2015; 45(1):59-69. PubMed ID: 26227734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.